Avalon Globocare Corp Financials
This page shows Avalon Globocare Corp (ALBT) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 10 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores
Avalon Globocare Corp's revenue declined 100% year-over-year, from $1.3M to $0. This contraction results in a growth score of 0/100.
Avalon Globocare Corp carries a low D/E ratio of 1.54, meaning only $1.54 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 71/100, indicating a strong balance sheet with room for future borrowing.
Avalon Globocare Corp's current ratio of 0.11 means current assets barely cover short-term liabilities. This tight liquidity results in a low score of 0/100, which could limit financial flexibility.
Avalon Globocare Corp generates a -197.8% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 0/100. This is down from -111.3% the prior year.
Avalon Globocare Corp passes 1 of 9 financial strength tests. 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), neither operating efficiency signal passes.
For every $1 of reported earnings, Avalon Globocare Corp generates $0.25 in operating cash flow (-$4.6M OCF vs -$18.3M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
Avalon Globocare Corp earns $-178.9 in operating income for every $1 of interest expense (-$7.6M vs $42K). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
Key Financial Metrics
Earnings & Revenue
Avalon Globocare Corp generated $0 in revenue in fiscal year 2025. This represents a decrease of 100.0% from the prior year.
Avalon Globocare Corp's EBITDA was -$5.3M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 30.8% from the prior year.
Avalon Globocare Corp reported -$18.3M in net income in fiscal year 2025. This represents a decrease of 131.1% from the prior year.
Avalon Globocare Corp earned $-5.64 per diluted share (EPS) in fiscal year 2025. This represents an increase of 33.2% from the prior year.
Cash & Balance Sheet
Avalon Globocare Corp held $109K in cash against $0 in long-term debt as of fiscal year 2025.
Avalon Globocare Corp had 8M shares outstanding in fiscal year 2025. This represents an increase of 456.2% from the prior year.
Margins & Returns
Avalon Globocare Corp's ROE was -197.8% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 86.6 percentage points from the prior year.
Capital Allocation
ALBT Income Statement
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $350K-0.1% | $350K+0.2% | $350K+147.5% | $141K-59.0% | $345K+5.3% | $328K-36.8% | $519K+15.5% | $449K |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | $0 | N/A |
| SG&A Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Income | -$76K+98.0% | -$3.9M-115.2% | -$1.8M-37.9% | -$1.3M-3.2% | -$1.3M+15.6% | -$1.5M-78.4% | -$843K+91.4% | -$9.8M |
| Interest Expense | $267K-74.7% | $1.1M+88.9% | $560K+142.3% | -$1.3M-341.8% | $547K-32.3% | $808K+7524.2% | $11K+101.6% | -$654K |
| Income Tax | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income | -$254K+98.1% | -$13.5M-442.2% | -$2.5M+8.9% | -$2.7M-62.3% | -$1.7M+21.2% | -$2.1M-55.9% | -$1.4M+85.7% | -$9.6M |
| EPS (Diluted) | $-0.06+99.0% | $-6.22-335.0% | $-1.43 | N/A | $-1.82 | $-2.85-53.2% | $-1.86 | N/A |
ALBT Balance Sheet
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $9.1M+14.3% | $8.0M-24.7% | $10.6M-49.4% | $21.0M+7.3% | $19.6M+0.2% | $19.5M-4.0% | $20.3M-1.2% | $20.6M |
| Current Assets | $2.1M+123.9% | $933K-66.6% | $2.8M-13.7% | $3.2M+131.7% | $1.4M+95.9% | $713K-8.3% | $778K-8.6% | $851K |
| Cash & Equivalents | $334K+65.7% | $202K-85.3% | $1.4M-52.1% | $2.9M+178.9% | $1.0M+410.6% | $201K-34.3% | $305K+7.0% | $285K |
| Inventory | $80K-7.4% | $86K-4.1% | $90K-2.3% | $92K | N/A | N/A | N/A | N/A |
| Accounts Receivable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $13.6M-9.8% | $15.1M+4.1% | $14.5M+4.5% | $13.9M-1.9% | $14.1M-6.3% | $15.1M+5.7% | $14.3M+8.1% | $13.2M |
| Current Liabilities | $13.6M-9.7% | $15.1M+4.3% | $14.4M+4.1% | $13.9M+12.6% | $12.3M+43.5% | $8.6M+10.1% | $7.8M+15.4% | $6.8M |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | -$4.5M+36.8% | -$7.1M-82.8% | -$3.9M-154.8% | $7.1M+31.5% | $5.4M+22.3% | $4.4M-27.0% | $6.1M-17.8% | $7.4M |
| Retained Earnings | -$103.9M-0.2% | -$103.6M-14.9% | -$90.2M-2.8% | -$87.7M-3.2% | -$84.9M-2.0% | -$83.3M-2.6% | -$81.1M-1.7% | -$79.8M |
ALBT Cash Flow Statement
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$1.4M-11.0% | -$1.2M+32.0% | -$1.8M-67.1% | -$1.1M+43.1% | -$1.9M-75.0% | -$1.1M-18.1% | -$916K-15.0% | -$796K |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -$12 |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -$796K |
| Investing Cash Flow | $658K | $0-100.0% | $95K | $0 | $0 | N/A | N/A | $12 |
| Financing Cash Flow | $835K+1348.5% | $58K-73.8% | $220K-92.4% | $2.9M+7.2% | $2.7M+153.0% | $1.1M+14.6% | $937K+27.6% | $734K |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
ALBT Financial Ratios
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | -21.8%+1087.8pp | -1109.6%-593.1pp | -516.5%+410.5pp | -927.0%-559.1pp | -367.9%+90.9pp | -458.8%-296.4pp | -162.4%+2016.3pp | -2178.8% |
| Net Margin | -72.6%+3768.2pp | -3840.9%-3131.3pp | -709.6%+1218.0pp | -1927.6%-1441.1pp | -486.5%+163.7pp | -650.2%-386.7pp | -263.5%+1862.8pp | -2126.3% |
| Return on Equity | N/A | N/A | N/A | -38.4%-7.3pp | -31.1%+17.2pp | -48.3%-25.7pp | -22.6%+107.1pp | -129.7% |
| Return on Assets | -2.8%+165.7pp | -168.5%-145.1pp | -23.4%-10.4pp | -13.0%-4.4pp | -8.6%+2.3pp | -10.9%-4.2pp | -6.7%+39.7pp | -46.4% |
| Current Ratio | 0.15+0.1 | 0.06-0.1 | 0.19-0.0 | 0.23+0.1 | 0.11+0.0 | 0.08-0.0 | 0.10-0.0 | 0.13 |
| Debt-to-Equity | -3.03-0.9 | -2.12+1.6 | -3.73-5.7 | 1.95-0.7 | 2.62-0.8 | 3.42+1.1 | 2.36+0.6 | 1.79 |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -177.2% |
Note: The current ratio is below 1.0 (0.11), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Frequently Asked Questions
What is Avalon Globocare Corp's annual revenue?
Avalon Globocare Corp (ALBT) reported $0 in total revenue for fiscal year 2025. This represents a -100.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Avalon Globocare Corp's revenue growing?
Avalon Globocare Corp (ALBT) revenue declined by 100% year-over-year, from $1.3M to $0 in fiscal year 2025.
Is Avalon Globocare Corp profitable?
No, Avalon Globocare Corp (ALBT) reported a net income of -$18.3M in fiscal year 2025.
What is Avalon Globocare Corp's EBITDA?
Avalon Globocare Corp (ALBT) had EBITDA of -$5.3M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
What is Avalon Globocare Corp's return on equity (ROE)?
Avalon Globocare Corp (ALBT) has a return on equity of -197.8% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Avalon Globocare Corp's operating cash flow?
Avalon Globocare Corp (ALBT) generated -$4.6M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Avalon Globocare Corp's total assets?
Avalon Globocare Corp (ALBT) had $23.4M in total assets as of fiscal year 2025, including both current and long-term assets.
What is Avalon Globocare Corp's current ratio?
Avalon Globocare Corp (ALBT) had a current ratio of 0.11 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
What is Avalon Globocare Corp's debt-to-equity ratio?
Avalon Globocare Corp (ALBT) had a debt-to-equity ratio of 1.54 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Avalon Globocare Corp's return on assets (ROA)?
Avalon Globocare Corp (ALBT) had a return on assets of -78.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Avalon Globocare Corp's cash runway?
Based on fiscal year 2025 data, Avalon Globocare Corp (ALBT) had $109K in cash against an annual operating cash burn of $4.6M. This gives an estimated cash runway of approximately 0 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
What is Avalon Globocare Corp's Piotroski F-Score?
Avalon Globocare Corp (ALBT) has a Piotroski F-Score of 1 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Avalon Globocare Corp's earnings high quality?
Avalon Globocare Corp (ALBT) has an earnings quality ratio of 0.25x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Avalon Globocare Corp cover its interest payments?
Avalon Globocare Corp (ALBT) has an interest coverage ratio of -178.9x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Avalon Globocare Corp?
Avalon Globocare Corp (ALBT) scores 18 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.